Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for<i> Helicobacter pylori</i> Eradication: A Meta-Analysis of Randomized Clinical Trials

Efficacy of vonoprazan-based triple therapy is superior to that of PPI-based triple therapy for first-line <i>H. pylori</i> eradication. Additionally, vonoprazan-based triple therapy is better tolerated than PPI-based triple therapy.